Nevertheless, strong F statistics of these IVs, ranging from 30.17 to 35 167.34, indicated that the possibility of weak instrument bias was negligible, and the identification of PSRC1 gene with therapeutic potential for CAD was further supported by evidence from its downstream proteins. This evidence concerns the gene PSRC1 and coronary artery disorder.